Bioharvest Sciences Financials
| CNVCF Stock | USD 6.15 0.03 0.49% |
With this module, you can analyze Bioharvest financials for your investing period. You should be able to track the changes in Bioharvest Sciences individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Bioharvest |
Understanding current and past Bioharvest Sciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bioharvest Sciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Bioharvest Sciences' assets may result in an increase in income on the income statement.
The data published in Bioharvest Sciences' official financial statements typically reflect Bioharvest Sciences' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Bioharvest Sciences' quantitative information. For example, before you start analyzing numbers published by Bioharvest accountants, it's essential to understand Bioharvest Sciences' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Bioharvest Sciences Stock Summary
Bioharvest Sciences competes with CbdMD, Evolus, Akanda Corp, Biofrontera, and Collegium Pharmaceutical. BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. Canna-V-Cell Sciences is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | CA09076J1084 |
| Business Address | 1140-625 Howe Street, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.bioharvest.com |
| Phone | 604 622 1186 |
| Currency | USD - US Dollar |
Bioharvest Sciences Key Financial Ratios
There are many critical financial ratios that Bioharvest Sciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bioharvest Sciences reports annually and quarterly.| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 | |||
| Beta | 1.02 | |||
| Z Score | 11.4 |
Bioharvest Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bioharvest Sciences's current stock value. Our valuation model uses many indicators to compare Bioharvest Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioharvest Sciences competition to find correlations between indicators driving Bioharvest Sciences's intrinsic value. More Info.Bioharvest Sciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioharvest Sciences' earnings, one of the primary drivers of an investment's value.Bioharvest Sciences Systematic Risk
Bioharvest Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bioharvest Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Bioharvest Sciences correlated with the market. If Beta is less than 0 Bioharvest Sciences generally moves in the opposite direction as compared to the market. If Bioharvest Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bioharvest Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bioharvest Sciences is generally in the same direction as the market. If Beta > 1 Bioharvest Sciences moves generally in the same direction as, but more than the movement of the benchmark.
Bioharvest Sciences December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bioharvest Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bioharvest Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bioharvest Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Bioharvest OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bioharvest Sciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.58 | |||
| Information Ratio | 0.0294 | |||
| Maximum Drawdown | 25.87 | |||
| Value At Risk | (4.00) | |||
| Potential Upside | 5.0 |
Complementary Tools for Bioharvest OTC Stock analysis
When running Bioharvest Sciences' price analysis, check to measure Bioharvest Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioharvest Sciences is operating at the current time. Most of Bioharvest Sciences' value examination focuses on studying past and present price action to predict the probability of Bioharvest Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioharvest Sciences' price. Additionally, you may evaluate how the addition of Bioharvest Sciences to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |